v3.25.2
Business Segment (Tables)
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Net Sales Information by Product Line These product lines' net sales are as follows:
Three Months Ended June 30,Six Months Ended June 30,
 2025202420252024
Orthopedic surgery$140,734 $139,537 $279,024 $274,449 
General surgery201,611 192,560 384,576 369,922 
Consolidated net sales$342,345 $332,097 $663,600 $644,371 
Schedule of Segment Reporting Information, by Segment The following table includes significant segment expenses:
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Net sales
$342,345 $332,097 $663,600 $644,371 
Cost of sales
154,025 148,368 297,529 288,677 
Salesforce and commission expense
58,923 57,320 116,355 112,595 
Marketing expense
16,992 16,428 32,867 31,950 
Distribution expense
13,152 12,825 25,185 24,792 
General and administrative expense
33,016 29,150 65,670 60,990 
Stock-based compensation expense
4,903 6,974 18,766 13,214 
Amortization expense
7,192 7,157 14,364 14,309 
Non-cash adjustments to fair value of contingent consideration liability(1,799)(8,673)2,163 (15,219)
Research and development expense
14,138 14,098 27,084 27,692 
Interest expense
7,824 9,593 16,110 19,188 
Other expense
418 — 418 — 
Provision for income taxes
8,498 7,538 10,134 13,248 
Other segment items(a)
3,642 1,343 9,498 3,250 
Net income
$21,421 $29,976 $27,457 $49,685 
(a)Other segment items consist of (i) third party services pertaining to review of potential issues with certain royalty payments to surgeons involved in design teams during the three and six months ended June 30, 2025 and 2024; (ii) cash compensation costs related to advisory services provided by our former Chief Executive Officer during the six months ended June 30, 2025; (iii) consulting fees related to operational optimization during the three and six months ended June 30, 2025; (iv) gain on the sale of a product line during the six months ended June 30, 2025; and (v) restructuring related costs and income related to the termination of a distributor agreement during the six months ended June 30, 2024.